An artificial intelligence model to predict hepatocellular carcinoma risk in Korean and Caucasian patients with chronic hepatitis B
JOURNAL OF HEPATOLOGY, cilt.76, sa.2, ss.311-318, 2022 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 76 Sayı: 2
- Basım Tarihi: 2022
- Doi Numarası: 10.1016/j.jhep.2021.09.025
- Dergi Adı: JOURNAL OF HEPATOLOGY
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database
- Sayfa Sayıları: ss.311-318
- Anahtar Kelimeler: liver cancer, deep neural networking, antiviral treatment, chronic hepatitis B, HCC, HBV, ENTECAVIR TREATMENT, SCORING SYSTEM, VALIDATION, LAMIVUDINE, CIRRHOSIS, THERAPY, HISTORY, SCORES
- Ankara Üniversitesi Adresli: Evet
Özet
Background & Aims: Several models have recently been developed to predict risk of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B (CHB). Our aims were to develop and validate an artificial intelligence-assisted prediction model of HCC risk.